Trial record 10 of 46 for:
child [AGE-GROUP] "drug abuse" | Open Studies
Pharmacological, Clinical and Statistical Assessment of a New Tool Available for Pharmacodependence Report Evaluation
The recruitment status of this study is unknown because the information has not been verified recently.
Verified January 2010 by Nantes University Hospital.
Recruitment status was Recruiting
Information provided by (Responsible Party):
Nantes University Hospital
First received: January 19, 2010
Last updated: January 31, 2012
Last verified: January 2010
In France, the Afssaps is the body in charge of the evaluation of pharmacodependance. In order to fulfil its mission, the Afssaps has created a network of 11 Centres for Evaluation and Information on Pharmacodependance (CEIP), coordinated by the Drugs and Psychotropics Unit. Pharmacodependence notifications issued by professionals are collected by each Centre which evaluates them. Nantes' CEIP created an original tool to harmonize case reporting and make it possible to homogeneously evaluate the seriousness of pharmacodependence cases as each CEIP had his own way of analysing his cases. The aim of this study is to assess this tool.
||Time Perspective: Prospective
||Pharmacological, Clinical and Statistical Assessment of a New Tool Available for Pharmacodependence Report Evaluation
Primary Outcome Measures:
- Psychometrics properties Evaluation of the new questionnaire centered on addiction to medicine . [ Time Frame: At the beginning of the study ] [ Designated as safety issue: No ]
| Estimated Enrollment:
| Study Start Date:
Case report from one of the French CEIP for drug and substance problematic use, abuse or dependence except alcohol and tobacco.
|Genders Eligible for Study:
|Accepts Healthy Volunteers:
- case report from one of the French CEIP for drug and substance problematic use, abuse or dependence except alcohol and tobacco.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.
For general information, see Learn About Clinical Studies.
Please refer to this study by its ClinicalTrials.gov identifier: NCT01052675
|Bordeaux, France, 33076 |
|CHRU de Caen
|Caen, France, 14033 |
|CHU de Grenoble
|Grenoble, France, 38043 |
|Centre Antipoison - Centre de Pharmacovigilance
|Lyon, France, 69424 |
|Marseille, France, 13274 |
|Montpellier, France, 34295 |
|CHU de Nancy
|Nancy, France, 54035 |
|CHU de Nantes
|Nantes, France, 44093 |
|Hôpital Fernand Widal
|Paris, France, 75475 |
|Faculté de médecine
|Toulouse, France, 31073 |
Nantes University Hospital
||Jolliet Pascale, MD
||Nantes's University Hospital
No publications provided
||Nantes University Hospital
History of Changes
|Other Study ID Numbers:
|Study First Received:
||January 19, 2010
||January 31, 2012
||France: Ministry of Health
Keywords provided by Nantes University Hospital:
ClinicalTrials.gov processed this record on June 30, 2015
Drug and substance problematic use, abuse or dependence